Pharmacokinetics of faster and standard insulin aspart during fully closed-loop insulin delivery in type 2 diabetes.

David Herzig, Joachim Dehais, Jean-Christophe Prost, Christos T Nakas, Christoph Stettler, Lia Bally & Roman Hovorka
Background Faster insulin aspart is a novel formulation of insulin aspart aiming to accelerate its subcutaneous absorption. The aim of the present study was to compare pharmacokinetics of faster insulin aspart versus standard insulin aspart in adults with type 2 diabetes during closed-loop insulin delivery. Methods We assessed the pharmacokinetics of faster and standard insulin aspart from data obtained in a randomized double-blind crossover study evaluating fully closed-loop insulin delivery in adults with type 2...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.